Atlanta Capital Management Co. L L C Sells 2,065 Shares of ICU Medical, Inc. (ICUI)

Atlanta Capital Management Co. L L C trimmed its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 1.5% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 140,174 shares of the medical instruments supplier’s stock after selling 2,065 shares during the quarter. Atlanta Capital Management Co. L L C owned approximately 0.70% of ICU Medical worth $26,051,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the business. Alps Advisors Inc. increased its holdings in shares of ICU Medical by 0.3% during the second quarter. Alps Advisors Inc. now owns 3,130 shares of the medical instruments supplier’s stock valued at $540,000 after purchasing an additional 8 shares during the period. Ameritas Investment Partners Inc. increased its holdings in shares of ICU Medical by 4.0% during the second quarter. Ameritas Investment Partners Inc. now owns 1,321 shares of the medical instruments supplier’s stock valued at $228,000 after purchasing an additional 51 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of ICU Medical by 10.3% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 707 shares of the medical instruments supplier’s stock valued at $122,000 after purchasing an additional 66 shares during the period. Martingale Asset Management L P increased its holdings in shares of ICU Medical by 0.3% during the second quarter. Martingale Asset Management L P now owns 38,703 shares of the medical instruments supplier’s stock valued at $6,677,000 after purchasing an additional 100 shares during the period. Finally, Arizona State Retirement System increased its holdings in shares of ICU Medical by 1.3% during the second quarter. Arizona State Retirement System now owns 7,874 shares of the medical instruments supplier’s stock valued at $1,358,000 after purchasing an additional 100 shares during the period. Institutional investors own 78.15% of the company’s stock.

ICUI has been the topic of a number of research analyst reports. Zacks Investment Research raised ICU Medical from a “sell” rating to a “hold” rating in a report on Monday, September 11th. BidaskClub lowered ICU Medical from a “hold” rating to a “sell” rating in a report on Thursday, August 24th. Finally, KeyCorp initiated coverage on ICU Medical in a report on Tuesday, October 17th. They set a “sector weight” rating on the stock. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $232.00.

In related news, Director Robert S. Swinney sold 1,000 shares of ICU Medical stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $215.10, for a total value of $215,100.00. Following the transaction, the director now owns 13,330 shares of the company’s stock, valued at approximately $2,867,283. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Joseph R. Saucedo sold 2,000 shares of ICU Medical stock in a transaction dated Tuesday, November 21st. The stock was sold at an average price of $216.06, for a total value of $432,120.00. Following the completion of the transaction, the director now directly owns 554,364 shares in the company, valued at approximately $119,775,885.84. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 119,663 shares of company stock worth $22,887,437. 13.60% of the stock is owned by corporate insiders.

ICU Medical, Inc. (NASDAQ ICUI) opened at $210.80 on Friday. The stock has a market capitalization of $4,243.61, a PE ratio of 82.67, a P/E/G ratio of 3.38 and a beta of 0.36. ICU Medical, Inc. has a fifty-two week low of $127.00 and a fifty-two week high of $218.45. The company has a current ratio of 4.65, a quick ratio of 3.01 and a debt-to-equity ratio of 0.07.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Thursday, November 9th. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.77 by $0.35. The firm had revenue of $343.20 million for the quarter, compared to analyst estimates of $328.56 million. ICU Medical had a return on equity of 4.81% and a net margin of 2.79%. ICU Medical’s revenue was up 253.5% compared to the same quarter last year. During the same period in the previous year, the company earned $1.35 earnings per share. analysts anticipate that ICU Medical, Inc. will post 3.95 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This news story was first published by Week Herald and is the property of of Week Herald. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://weekherald.com/2017/12/10/atlanta-capital-management-co-l-l-c-sells-2065-shares-of-icu-medical-inc-icui.html.

ICU Medical Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply